Prime Medicine PRME Financing Cash Flow
Financing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Prime Medicine in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.
The official record: Prime Medicine’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Prime Medicine's financing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Prime Medicine's financing cash flow?
- Prime Medicine (PRME) reported financing cash flow of $393K in Q1 2026.
- How has Prime Medicine's financing cash flow changed year-over-year?
- Prime Medicine's financing cash flow decreased by 93.5% year-over-year, from $6M to $393K.
- What is the long-term trend for Prime Medicine's financing cash flow?
- Over 4 years (2021 to 2025), Prime Medicine's financing cash flow has grown at a -13.4% compound annual growth rate (CAGR), from $269.28M to $151.51M.
- What does financing cash flow mean?
- Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.